IDEX (IEX) Resumen de Acciones
IDEX Corporation, junto con sus filiales, ofrece soluciones aplicadas en Estados Unidos, Norteamérica, Europa, Asia y a escala internacional. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 3/6 |
| Crecimiento futuro | 1/6 |
| Rendimiento pasado | 4/6 |
| Salud financiera | 4/6 |
| Dividendos | 4/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en IEX a partir de nuestros controles de riesgos.
IEX Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de IDEX Corporation
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$219.74 |
| Máximo en las últimas 52 semanas | US$230.18 |
| Mínimo de 52 semanas | US$157.25 |
| Beta | 0.97 |
| Cambio en 1 mes | -1.08% |
| Variación en 3 meses | 9.27% |
| Cambio de 1 año | 18.51% |
| Variación en 3 años | 3.35% |
| Variación en 5 años | -2.20% |
| Variación desde la OPV | 7,506.38% |
Noticias y actualizaciones recientes
Seeking Alpha • Jul 03
IDEX Corporation: Healthy End-Market Demand Supports Growth, But Premium Valuation Warrants Caution
Summary IDEX Corporation is rated Hold, as its premium P/E valuation is not justified by growth relative to peers. Strong HST segment growth and AI-driven demand should drive FY2026 revenue, but FMT segment weakness remains a headwind. Margins benefit from volume leverage and favorable price/cost, but unfavorable mix and low-margin acquisitions pressure profitability. With a 26.48x P/E versus a 21.8x peer median, IEX's superior margins do not warrant the current valuation premium. Read the full article on Seeking AlphaArtículo de análisis • Jun 16
Idex (IEX) Stock Valuation Check After Recent Gains And Conflicting P/E And DCF Signals
Recent performance snapshot and what it means for IDEX (IEX) IDEX (IEX) has drawn fresh attention after a steady run, with the stock last closing at US$222.04 and total return figures highlighting how the company has been tracking over different holding periods. Over the past month, IDEX shows a 6.9% return, and about 16.6% over the past 3 months, with year to date performance at 24% and a 1 year total return of 25.3%. Longer holding periods show total returns of 10.3% over 3 years and 9%...
Actualización de narrativa • Jun 16
IEX: Steady Buybacks And Dividend Record Will Support Future Returns
Analysts have nudged their price target on IDEX slightly higher to about $238 per share, reflecting small adjustments to fair value, discount rate, long term revenue growth, profit margin, and future P/E assumptions in their models. What's in the News IDEX's board approved a regular quarterly cash dividend of US$0.73 per common share, scheduled for payment on June 5, 2026, to shareholders of record on May 22, 2026, marking the company’s 126th consecutive regular quarterly dividend (Key Developments).Recent updates
Seeking Alpha • Jul 03
IDEX Corporation: Healthy End-Market Demand Supports Growth, But Premium Valuation Warrants Caution
Summary IDEX Corporation is rated Hold, as its premium P/E valuation is not justified by growth relative to peers. Strong HST segment growth and AI-driven demand should drive FY2026 revenue, but FMT segment weakness remains a headwind. Margins benefit from volume leverage and favorable price/cost, but unfavorable mix and low-margin acquisitions pressure profitability. With a 26.48x P/E versus a 21.8x peer median, IEX's superior margins do not warrant the current valuation premium. Read the full article on Seeking AlphaArtículo de análisis • Jun 16
Idex (IEX) Stock Valuation Check After Recent Gains And Conflicting P/E And DCF Signals
Recent performance snapshot and what it means for IDEX (IEX) IDEX (IEX) has drawn fresh attention after a steady run, with the stock last closing at US$222.04 and total return figures highlighting how the company has been tracking over different holding periods. Over the past month, IDEX shows a 6.9% return, and about 16.6% over the past 3 months, with year to date performance at 24% and a 1 year total return of 25.3%. Longer holding periods show total returns of 10.3% over 3 years and 9%...Actualización de narrativa • Jun 16
IEX: Steady Buybacks And Dividend Record Will Support Future Returns
Analysts have nudged their price target on IDEX slightly higher to about $238 per share, reflecting small adjustments to fair value, discount rate, long term revenue growth, profit margin, and future P/E assumptions in their models. What's in the News IDEX's board approved a regular quarterly cash dividend of US$0.73 per common share, scheduled for payment on June 5, 2026, to shareholders of record on May 22, 2026, marking the company’s 126th consecutive regular quarterly dividend (Key Developments).Actualización de narrativa • Jun 01
IEX: Dividend Strength And AI-Driven Demand Should Support Future Returns
Analysts have maintained their $237.71 price target for IDEX, citing only very small adjustments in the discount rate, revenue growth, profit margin, and future P/E assumptions as the reasons for leaving their valuation unchanged. What's in the News IDEX reported first quarter fiscal 2026 results that came in stronger than expected, according to recent Wall Street coverage.Actualización de narrativa • May 14
IEX: Dividend Strength And Buybacks Will Support Returns Going Forward
Analysts have adjusted their price target on IDEX to $237.71 from $222.71, reflecting updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News IDEX Corporation's Board of Directors approved a regular quarterly cash dividend of $0.73 per common share, scheduled to be paid on June 5, 2026, to shareholders of record on May 22, 2026.Actualización de narrativa • Apr 26
IEX: Balanced Outlook As Buybacks And M&A Plans Will Shape Returns
Analysts now project only a slight reduction in IDEX's fair value estimate, with the updated price target moving from about $222.93 to $222.71. This reflects modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E.Actualización de narrativa • Apr 12
IEX: Balanced Outlook As Buybacks And M&A Plans Shape Future Returns
Analysts have inched their price target for IDEX lower to about $223 from roughly $224, reflecting slightly revised assumptions on fair value, discount rate and forward P/E, while keeping revenue growth and profit margin expectations broadly unchanged. What's in the News IDEX completed a share repurchase tranche from October 1, 2025 to February 19, 2026, buying 632,280 shares for US$113.1 million, equal to 0.84% of shares under the existing program (Key Developments).Actualización de narrativa • Mar 28
IEX: Ongoing Buybacks And M&A Focus Will Support Future Upside
Analysts have slightly reduced their IDEX price target to $224.29 from $225.08, citing minor model updates to fair value, discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News IDEX completed a share repurchase program announced on April 21, 2008, buying back a total of 19,293,107 shares for US$1,623.91m, representing 24.31% of the company (Key Developments).Actualización de narrativa • Mar 14
IEX: Ongoing M&A And Buybacks Will Support Attractive Future Upside
Analysts have raised their price target on IDEX to about $225 from roughly $224, reflecting slightly updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News IDEX is actively pursuing mergers and acquisitions, with management describing the company as about halfway through a multiyear capital deployment cycle focused on building out existing platforms and markets (Key Developments).Actualización de narrativa • Feb 27
IEX: Future CFO And Continued M&A Will Support Steady Outlook
Analysts have kept their average IDEX price target broadly steady around $223.54, with only marginal tweaks to inputs such as the discount rate and assumed future P/E multiple to reflect updated views on the company’s risk profile and valuation framework. What's in the News IDEX is actively pursuing mergers and acquisitions, with management indicating they see themselves around the midpoint of a long term capital deployment cycle and planning additional deals to build out existing market positions, using prior acquisition activity as a reference point for future bolt on targets (Key Developments).Actualización de narrativa • Feb 13
IEX: Future CFO Transition And Ongoing Buybacks Will Support Steady Outlook
Analysts have lifted their price target on IDEX to $223.54 from $198.62, reflecting updated assumptions that include a slightly lower discount rate and modest tweaks to revenue growth, profit margin, and future P/E expectations. What's in the News IDEX completed a share repurchase tranche between October 1, 2025 and December 31, 2025, buying 400,000 shares, or 0.53% of the company, for $75 million under its long running buyback program announced on April 21, 2008 (Key Developments).Actualización de narrativa • Jan 30
IEX: Future CFO Transition And Capital Deployment Will Support Steady Outlook
Analysts have nudged their price target on IDEX higher to about US$199 from roughly US$197, citing updated assumptions that include a slightly lower discount rate, modest tweaks to revenue growth and profit margin expectations, and a marginally higher future P/E estimate. What's in the News IDEX appointed Sean M.Actualización de narrativa • Jan 15
IEX: Future CFO Appointment And Buybacks Will Support Steady Outlook
Analysts have modestly raised their fair value estimate for IDEX to US$197.08 from US$194.62, citing slightly lower assumed revenue growth and profit margins that are offset by a higher future P/E multiple and updated discount rate assumptions. What's in the News IDEX appointed Sean M.Artículo de análisis • Jan 07
These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Jul 23
Why IDEX Corporation (NYSE:IEX) Could Be Worth Watching
IDEX Corporation ( NYSE:IEX ) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE...Seeking Alpha • Apr 27
IDEX Corporation: It's Best To Remain Cautious As Earnings Near
Summary IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns. Awaiting Q1 2025 results on May 1st, IDEX's stock remains fairly valued compared to peers, but not attractive enough for an upgrade. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
IDEX: A Wonderful Mid-Cap Focused On Long-Term Value Generation
Summary IDEX Corporation is a niche industrial manufacturer with a wide economic moat, producing mission-critical products with significant pricing power and high switching costs. Despite softer 2024 earnings, IDEX remains highly profitable with robust margins and a strong balance sheet. The firm's strategic acquisitions and entrenched customer relationships bolster its market position, ensuring continued growth and competitive insulation. Given the fair valuation and conservative fiscal management, I rate IDEX a Hold, awaiting a larger undervaluation for a potential buy. Read the full article on Seeking AlphaSeeking Alpha • Nov 06
IDEX Corporation: A Demanding Valuation For A Great Business
Summary IDEX Corporation faces sluggish organic growth and slower order intake, yet it maintains a strong long-term value proposition through mission-critical industrial and technology solutions. Despite a solid historical performance, current valuation multiples are demanding, especially given the flattish reported results. The company’s recent $1 billion acquisition of Mott is strategically aligned but comes at a high valuation, reflecting IDEX’s increased reliance on M&A for growth. Shares have risen to $235, driven by optimism, but I remain cautious due to lackluster operating performance and heightened expectations at nearly 30 times earnings. Read the full article on Seeking AlphaSeeking Alpha • Sep 02
IDEX Corp. Q2: Project Delay And Weakness In Life Science
Summary I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance. Long-term growth prospects remain strong due to active portfolio management, strategic acquisitions, and anticipated recovery in industrial activities and life science markets by 2025. Read the full article on Seeking AlphaSeeking Alpha • Jul 11
IDEX Corp.: There Are Better Opportunities Out There
Summary IDEX Corporation's revenue grew slightly in 2024, but profitability weakened due to a drop in sales and rising costs. Management remains optimistic about organic revenue growth and adjusted net income for the year. Despite being a high-quality business, IDEX Corporation's shares are not attractively priced, making it a better 'hold' than a 'buy' prospect. Read the full article on Seeking AlphaSeeking Alpha • Jun 30
IDEX: Order Moderation Illuminating A Path Forward
Summary Order moderation in Q1 FY24 indicates initial recovery in end-markets and completion of inventory destocking. IDEX reaffirmed full-year guidance of 0%-2% organic revenue growth, anticipating end-market recovery in the second half of FY24. I predict 7% organic revenue growth from FY25 onwards, with fair value estimated at $220 per share. Read the full article on Seeking AlphaRentabilidad de los accionistas
| IEX | US Machinery | Mercado US | |
|---|---|---|---|
| 7D | -1.8% | -2.1% | 0.6% |
| 1Y | 18.5% | 35.9% | 19.5% |
Rentabilidad vs. Industria: Los resultados de IEX fueron inferiores a los de la industria US Machinery, que obtuvo un rendimiento del 35.9% el año pasado.
Rentabilidad vs. Mercado: IEX igualó el mercado US, que obtuvo un rendimiento del 19.5% el año pasado.
Volatilidad de los precios
| IEX volatility | |
|---|---|
| IEX Average Weekly Movement | 3.3% |
| Machinery Industry Average Movement | 6.5% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Precio estable de las acciones: IEX no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de IEX (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1987 | 8,700 | Eric Ashleman | www.idexcorp.com |
IDEX Corporation, junto con sus filiales, ofrece soluciones aplicadas en Estados Unidos, Norteamérica, Europa, Asia e internacionalmente. Opera a través de tres segmentos: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) y Fire & Safety/Diversified Products (FSDP). El segmento HST diseña, produce y distribuye una gama de productos de fluídica de precisión, bombas de desplazamiento positivo, tecnologías de procesamiento de polvos y líquidos, sistemas de secado, componentes de microprecisión, componentes neumáticos y soluciones de sellado, componentes de sellado moldeados y extruidos de alto rendimiento, y cierres mecánicos y de eje personalizados.
Resumen de fundamentos de IDEX Corporation
| Estadísticas fundamentales de IEX | |
|---|---|
| Capitalización bursátil | US$16.16b |
| Beneficios(TTM) | US$507.70m |
| Ingresos (TTM) | US$3.53b |
32.0x
Ratio precio-beneficio (PE)4.6x
Ratio precio-ventas (PS)¿Está IEX sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de IEX | |
|---|---|
| Ingresos | US$3.53b |
| Coste de los ingresos | US$1.96b |
| Beneficio bruto | US$1.57b |
| Otros gastos | US$1.06b |
| Beneficios | US$507.70m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
Jul 29, 2026
| Beneficios por acción (BPA) | 6.86 |
| Margen bruto | 44.44% |
| Margen de beneficio neto | 14.38% |
| Ratio deuda/patrimonio | 46.2% |
¿Cómo se ha desempeñado IEX a largo plazo?
Ver rendimiento histórico y comparativaDividendos
1.3%
Rentabilidad actual por dividendo31%
Ratio de pagos¿Paga IEX dividendos fiables?
Ver historial de dividendos e índices de referencia de IEX| fechas de dividendos de IDEX | |
|---|---|
| Fecha ex dividendo | Jul 06 2026 |
| Fecha de pago de dividendos | Jul 24 2026 |
| Días hasta ex dividendo | 4 days |
| Días hasta la fecha de pago de dividendos | 14 days |
¿Paga IEX dividendos fiables?
Ver historial de dividendos e índices de referencia de IEXAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/07/09 07:05 |
| Precio de las acciones al final del día | 2026/07/09 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
IDEX Corporation está cubierta por 28 analistas. 14 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| John Eade | Argus Research Company |
| Michael Halloran | Baird |
| Walter Liptak | Barrington Research Associates, Inc. |